一致Ｂ：2022年半年度报告（英文版）.PDF

1、China National Accord Medicines Corporation Ltd.Semi-Annual Report 2022 August 2022 1 Section I.Important Notice,Contents and Interpretation Board of Directors,Supervisory Committee,all directors,supervisors and senior executives of China National Accord Medicines Corporation Ltd.(hereinafter referr

2、ed to as the Company)hereby confirm that there are no any fictitious statements,misleading statements,or important omissions carried in this report,and shall take all responsibilities,individual and/or joint,for the reality,accuracy and completion of the whole contents.Lin Zhaoxiong,Principal of the

3、 Company,Gu Guolin,person in charger of accounting works and Wang Ying,person in charge of accounting organ(accounting principal)hereby confirm that the Financial Report of Semi-Annual Report 2022 is authentic,accurate and complete.All directors are attended the Board Meeting for report deliberation

4、.2 Contents Section I.Important Notice,Contents and Interpretation.1 Section II Company Profile and Main Financial Indexes.4 Section III Management Discussion and Analysis.8 Section IV Corporate Governance.34 Section V Environmental and Social Responsibility.35 Section VI.Important Events.39 Section

5、 VII.Changes in Shares and Particulars about Shareholders.79 Section VIII.Preferred Stock.85 Section IX.Corporate Bonds.86 Section X.Financial Report.87 3 Documents Available for Reference I.The financial statements carried with the signature and seals of legal representative,person in charger of ac

6、counting works and person in charge of accounting organ;II.Original text of all documents of the Company as well as the manuscript of the announcement disclosed in the reporting period on Juchao Website.III.Text of the Semi-Annual Report 2022 bearing the signature of the legal representative.Interpr